Coronary Artery Calcium and Statin Allocation in the Era of PREVENT: Evidence from MESA
Highlight
– The 2026 AHA/ACC dyslipidemia guideline incorporates the PREVENT calculator for 10-year ASCVD risk evaluation, superseding the Pooled Cohort Equations.
– Coronary artery calcium (CAC) scoring effectively stratifies atherosclerotic cardiovascular disease (ASCVD) risk, especially in patients with borderline statin eligibility.
– Individuals with absent CAC still experience significant ASCVD event rates when statin therapy is guideline-recommended, suggesting CAC 0 should not replace guideline-based statin initiation.
– CAC scoring provides nuanced risk refinement near statin treatment thresholds, guiding prevention intensity and personalized therapy decisions.
Study Background
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.